FDA Commissioner on Trump's Deal to Lower Drug Prices with Pfizer

The End of the 'Great American Ripoff'

• 💊 The FDA Commissioner declares the announcement marks the beginning of the end of the 'great American ripoff' in drug pricing.
• 💔 He describes the tragedy of patients facing severe financial strain, resorting to GoFundMe and church collections to afford medications in the US.
• 📉 Financial toxicity from high drug costs leads 37% of cancer patients to avoid or delay future care.

Reforming Drug R&D and Pricing

• 🇺🇸 The US has historically financed global R&D through higher drug prices, a practice that the speaker states ends today under President Trump.
• 💰 Pharmaceutical companies are incentivized to equalize US prices with those in other wealthy nations like Germany, France, and the UK.
• 🚀 In return for equalizing prices, companies will receive priority review for their future applications, a voucher valued at approximately $500 million.

FDA's Role in Manufacturing and Pricing

• 🏭 Companies meeting national priorities such as moving manufacturing to the US, addressing public health needs, or equalizing prices will benefit from FDA support.
• 📈 Generic companies manufacturing drugs in the US will also have their applications moved to the front of the line.
• 🏗️ FDA inspectors will provide unprecedented support by walking through new US plants during construction to ensure they are ready on day one.